Skip to main content
Fig. 3 | Stem Cell Research & Therapy

Fig. 3

From: Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures

Fig. 3

PTH induces hMSC differentiation into osteoprogenitor cells. Immunohistochemistry was performed on tissue samples harvested 8 weeks after surgery. The sections were stained with antibodies against the well-established osteogenic markers osteocalcin (Oc) and bone sialoprotein (BSP), in addition to DAPI staining. Yellow arrows indicate bone defect margins; orange arrows indicate co-staining of DiI and bone markers. MSCs mesenchymal stem cells, PTH parathyroid hormone

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512